Skip to main content

Published locations for Palonosetron Plus 1-Day Dexamethasone for the Prevention of Nausea and Vomiting Due to Moderately Emetogenic Chemotherapy: Effect of Established Risk Factors on Treatment Outcome in a Phase III Trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Palonosetron Plus 1-Day Dexamethasone for the Prevention of Nausea and Vomiting Due to Moderately Emetogenic Chemotherapy: Effect of Established Risk Factors on Treatment Outcome in a Phase III Trial

User login

  • Reset your password
  • /content/palonosetron-plus-1-day-dexamethasone-prevention-nausea-and-vomiting-due-moderately
  • /jcso/article/49037/patient-survivor-care/palonosetron-plus-1-day-dexamethasone-prevention-nausea-and
  • /hematology-oncology/article/49037/patient-survivor-care/palonosetron-plus-1-day-dexamethasone